{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:17:10Z","timestamp":1790252230289,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001823","name":"Ministry of Education Youth and Sports of the Czech Republic","doi-asserted-by":"publisher","award":["LM2023050"],"award-info":[{"award-number":["LM2023050"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministry of Education Youth and Sports of the Czech Republic","doi-asserted-by":"publisher","award":["LM2023053"],"award-info":[{"award-number":["LM2023053"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["24\\u201314579L"],"award-info":[{"award-number":["24\\u201314579L"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118216","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:51:38Z","timestamp":1758941498000},"page":"118216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Repurposing carboplatin-based Pt(IV)-deferoxamine conjugates for infection theranostics"],"prefix":"10.1016","volume":"301","author":[{"given":"Martin","family":"Kraihammer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hristo P.","family":"Varbanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate\u0159ina","family":"Dvo\u0159\u00e1kov\u00e1 Bendov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milo\u0161","family":"Pet\u0159\u00edk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Gariglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubertus","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Decristoforo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118216_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171052","article-title":"Repositioning approved drugs for the treatment of problematic cancers using a screening approach","volume":"12","author":"Varbanov","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.118216_bib2","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1039\/D1DT00214G","article-title":"Multifunctional Pt(iv) prodrug candidates featuring the carboplatin core and deferoxamine","volume":"50","author":"Harringer","year":"2021","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2025.118216_bib3","doi-asserted-by":"crossref","first-page":"20745","DOI":"10.1021\/acs.inorgchem.3c02245","article-title":"Radiometal-labeled photoactivatable Pt(IV) anticancer complex for theranostic phototherapy","volume":"62","author":"Imberti","year":"2023","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118216_bib4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s00259-020-04948-y","article-title":"68Ga-labelled desferrioxamine-B for bacterial infection imaging","volume":"48","author":"Petrik","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.ejmech.2025.118216_bib5","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1021\/acs.organomet.7b00885","article-title":"Applying a trojan horse strategy to ruthenium complexes in the pursuit of novel antibacterial agents","volume":"37","author":"Laurent","year":"2018","journal-title":"Organometallics"},{"key":"10.1016\/j.ejmech.2025.118216_bib6","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3390\/jof7090734","article-title":"Desferrioxamine B-mediated pre-clinical in vivo imaging of infection by the mold fungus Aspergillus fumigatus","volume":"7","author":"Misslinger","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.ejmech.2025.118216_bib7","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s10096-018-3251-5","article-title":"Invasive pulmonary aspergillosis: current diagnostic methodologies and a new molecular approach","volume":"37","author":"Moura","year":"2018","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.118216_bib8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3390\/jof4030098","article-title":"Treatment of aspergillosis","volume":"4","author":"Jenks","year":"2018","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.ejmech.2025.118216_bib9","doi-asserted-by":"crossref","first-page":"S259","DOI":"10.1093\/infdis\/jiad067","article-title":"Radiotracer development for fungal-specific imaging: past, present, and future","volume":"228","author":"Lai","year":"2023","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.118216_bib10","article-title":"Aspergillus fumigatus-a systematic review to inform the World Health Organization priority list of fungal pathogens","volume":"62","author":"Morrissey","year":"2024","journal-title":"Med. Mycol."},{"key":"10.1016\/j.ejmech.2025.118216_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/jof6020073","article-title":"Siderophore-based molecular imaging of fungal and bacterial infections-current status and future perspectives","volume":"6","author":"Petrik","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.ejmech.2025.118216_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae631.2282","article-title":"P-2126. \u2018SPECIFIC\u2019 first-in-human clinical trial of 68Ga-triacetylfusarinine (TAFC) siderophore PET\/CT for detection of invasive aspergillosis","volume":"12","author":"Sim","year":"2025","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.118216_bib13","first-page":"331","article-title":"Safety, pharmacokinetics, radiation dosimetry and preliminary diagnostic performance of [68Ga]Ga-deferoxamin in patients with bacterial infections - results from a Phase I\/IIa study. EANM\u201924 Abstract Book Congress Oct 19-23, 2024","volume":"51","author":"Decristoforo","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.ejmech.2025.118216_bib14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/jof7070558","article-title":"Antifungal siderophore conjugates for theranostic applications in invasive pulmonary aspergillosis using low-molecular TAFC Scaffolds","volume":"7","author":"Pfister","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.ejmech.2025.118216_bib15","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3390\/jof7090768","article-title":"The siderophore transporters Sit1 and Sit2 are essential for utilization of Ferrichrome-, ferrioxamine- and coprogen-type siderophores in Aspergillus fumigatus","volume":"7","author":"Aguiar","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.ejmech.2025.118216_bib16","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1099\/jmm.0.001172","article-title":"Repurposing bioactive compounds for treating multidrug-resistant pathogens","volume":"69","author":"Hummell","year":"2020","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.ejmech.2025.118216_bib17","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/ja.2010.64","article-title":"Antimicrobial spectrum of the antitumor agent, cisplatin","volume":"63","author":"Joyce","year":"2010","journal-title":"J. Antibiot."},{"key":"10.1016\/j.ejmech.2025.118216_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00807-19","article-title":"The siderophore transporter Sit1 determines susceptibility to the antifungal VL-2397","volume":"63","author":"Dietl","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.118216_bib19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/jof6040367","article-title":"Siderophore scaffold as carrier for antifungal peptides in therapy of Aspergillus fumigatus infections","volume":"6","author":"Pfister","year":"2020","journal-title":"Journal of Fungi"},{"key":"10.1016\/j.ejmech.2025.118216_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00280-002-0462-2","article-title":"Rapid biotransformation of satraplatin by human red blood cells in vitro","volume":"50","author":"Carr","year":"2002","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118216_bib21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00280-005-0069-5","article-title":"Satraplatin activation by haemoglobin, cytochrome C and liver microsomes in vitro","volume":"57","author":"Carr","year":"2006","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118216_bib22","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.1039\/C7DT04537A","article-title":"The impact of whole human blood on the kinetic inertness of platinum(iv) prodrugs \u2013 an HPLC-ICP-MS study","volume":"47","author":"Theiner","year":"2018","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2025.118216_bib23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1021\/acs.oprd.5b00379","article-title":"Process development of the synthesis and purification of a reactive immuno-PET conjugate intermediate","volume":"20","author":"Carrera","year":"2016","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.ejmech.2025.118216_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.mec.2022.e00214","article-title":"Characterization and engineering of the xylose-inducible xylP promoter for use in mold fungal species","volume":"15","author":"Yap","year":"2022","journal-title":"Metab Eng Commun"},{"key":"10.1016\/j.ejmech.2025.118216_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0065-2660(08)60408-3","article-title":"The Genetics of Aspergillus nidulans","author":"Pontecorvo","year":"1953","journal-title":"Adv. Genet."},{"key":"10.1016\/j.ejmech.2025.118216_bib28","series-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi","year":"2008"},{"key":"10.1016\/j.ejmech.2025.118216_bib29","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1007\/s00259-011-1818-9","article-title":"Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607","volume":"38","author":"Ocak","year":"2011","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.ejmech.2025.118216_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2018.02356","article-title":"Early and non-invasive diagnosis of aspergillosis revealed by infection kinetics monitored in a rat model","volume":"9","author":"Skriba","year":"2018","journal-title":"Front. Microbiol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342500981X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342500981X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T09:24:27Z","timestamp":1773134667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342500981X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":28,"alternative-id":["S022352342500981X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118216","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing carboplatin-based Pt(IV)-deferoxamine conjugates for infection theranostics","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118216"}}